Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × Liposomes × Clear all

NCT00761644 2019-04-11

Doxil, Bevacizumab and Temsirolimus Trial

Phase 1 Completed

Neoplasm Metastasis

NCT01333423 2012-06-26

Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Phase 1 Withdrawn

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms